Evidence map›Paper›PMID 38899879›Full record

ArticleInfection and immunity2024

Recognition of

Aissata Diallo, Grace Overman, Prakash Sah, George W Liechti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Infection and immunity · 2026
    Article
  3. Review
  4. Disrupted Cervicovaginal Microbiota: Its Role inInternational journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Aissata DialloDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
Grace OvermanDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
Prakash SahDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
George W LiechtiDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.ORCID 0000-0003-3028-8474

Funding

Cellular organization, division, and differentiation in an ancient, genetically reduced bacteriumR35GM138202 · NIGMS · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI GEORGE WARREN LIECHTI · 2020 to 2026
$2.0M
DOD | Uniformed Services University of the Health Sciences (USU) HP73LIEC18HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM138202NIGMS NIH HHS R35 GM138202
6 · The paper itself

Abstract

Toll-like receptor 9 (TLR9) is an innate immune receptor that localizes to endosomes in antigen presenting cells and recognizes single stranded unmethylated CpG sites on bacterial genomic DNA (gDNA). Previous bioinformatic studies have demonstrated that the genome of the human pathogen

Indexed as

Chlamydia InfectionsChlamydia trachomatisSignal TransductionToll-Like Receptor 9AnimalsCell LineDNA, BacterialHEK293 CellsHumansMiceDNA, BacterialTLR9 protein, humanToll-Like Receptor 9Chlamydiainnate immunitypathoadaptationpersistenceTLR9

Identifiers

PMID38899879
PMCPMC11238561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.